chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a healthcare professional via a sales representative and described the occurrence of acute bronchitis in a 4-year-old female subject who was vaccinated with KINRIX (GlaxoSmithKline). In September 2008 the subject received 1st dose of KINRIX at 0.5 ml in an unknown arm. At an unspecified time after vaccination with KINRIX, the subject experienced severe acute bronchitis. The subject was hospitalised for 3 days and the healthcare professional considered the event was life threatening and clinically significant (or requiring intervention). At the time of reporting the outcome of the event was unspecified. The healthcare professional considered the event was possibly related to vaccination with KINRIX.
pt recv vax OCT96 & 18DEC96 pt could not eat, had h/a, chills, fever 103, nausea, diarrhea, & gen weakness;pt has not yet recovered;
Pt became pale and limp, eyes glazed and rolled upward slightly. This happened after injection of Prevnar. Lasted only a few seconds. Called 911 fire dept  responded 1st. Ambulance came. Mother refused transport to hospital
Pt vaccinated with Influenza developed breathing difficulty, chocking snesatins. Given Epinphrine
After the vaccine shot given around 3 PM , she was fine for the first 30 minutes of observation. 4 hrs later while at home she developed fever, chills for about 1 hr then followed by shortness of breath with palpitation. She also developed nausea with myalgia. She continued to have shortness of breath and palpitation throughout the night. . She tried to take deep breaths and tried to be active. She went to school the following day  as a school teacher and she was monitored by  her co-teachers . Finally at 10 am her symptoms according to he disappeared .
Information has been received from a medical assistant referring to a 4 month old male patient. No relevant medical history or concurrent conditions were reported. On 08-JUN-2015, the patient was inadvertently vaccinated with improperly stored ROTATEQ (lot # K014826, expiration date 28-MAY-2016; dose was not reported) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Original report is MARRS#1507USA011322. Additional information has been requested.
Case number PHHY2016US160075 is an initial spontaneous report received from other health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 644800) on 21 Nov 2016. This report refers to unknown demographics patient. Medical history and concomitant medication was not reported. The patient was vaccinated with seasonal influenza virus vaccine (unknown manufacturer) on an unknown date. On an unknown date, following the vaccination the patient developed possible allergic reaction to vaccine. The lab test and corrective treatment were not reported. The outcome of the event was not reported. The seriousness and causality of the events was not reported.
20 minutes after shot numbness and tingly in left side of face only lasting about an hour.  1/29 @ 8:00 pm soreness at injection site continuing still (49+ hours). 1/29 @ 11:00 pm shaking and chills lasting all night with sweating, severe myalgias, fatigue, headache and fever (100.6). On 1/29, before going to bed, 1 took Benadryl with no relief. Confined to bed for 24 continuous hours (1/30).  On 1/30 I took Tylenol with minimal relief. Tightness of chest on 1/31. Headache continues currently (1/31), chills, fever and sweating resolved.
Information has been received from a nurse practitioner concerning her sister who was vaccinated with a first dose of GARDASIL in arm.  On unknown date the patient experienced breakthrough bleeding and spotting.  On unspecified date, the patient recovered from breakthrough bleeding and spotting.  The patient sought unspecified medical attention.  This is one of several reports from the same source.  Additional information has been requested.
DBD blood clot in leg; Arm got little sore; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (DBD blood clot in leg) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was reported.). Concomitant products included RIVAROXABAN (XARELTO) for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm got little sore). On 05-Apr-2021, the patient experienced THROMBOSIS (DBD blood clot in leg) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (DBD blood clot in leg) outcome was unknown and PAIN IN EXTREMITY (Arm got little sore) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Reportedly, the patient's sore arm went away pretty fast. The patient received treatment with Xarelto (Rivaroxaban) for blood clot in his leg.  Company Comment  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact
Patient was given 0.3 ml for the dose when it should have been 0.5 ml.
pt recvd vax;? sz;studies done,no dx made;on 9nov94 mom reported that pt has periods of jerky mvts on 1nov,3nov,9nov;no fever present;no evidence of local rxn;advised to discuss w/ family MD;
Temperature 102-104 starting within 8 hours of vaccines, along with fussiness. Lasted 2 days.
Fever began day after the vaccine and lasted for 4 days, maximum temp 102.8.  Rash started 4 days after vaccine and still persists.  Irritability, sore legs, but no obvious arthritis.  Mild facial puffiness 6 days after vaccine but no other allergy signs.  Rash is fine pink papules on the trunk and upper legs, not urticaria or petichiae. Rash does not include palm and soles.  No daycare exposure and family members all well presently.
Patient received 2nd dose of vaccine.  He had dizziness upon sitting up, flushing all over, and hypotensive.  Patient was observed 1801-1830 in vaccination observation area.  He was placed in the given water and then placed recumbent position.  There was no change.  He did improve with juice PO.  DR was notified and does not think this is an anaphylactic reaction, but should be transferred to the ED for further evaluation.  Patient was transferred to the ED.
This spontaneous report as received from a female patient of unknown age who is allergic to LEVAQUIN, allergic to ZITHROMAX, has varied sensitivities and allergy to synthetic fibers like nylon. The patient's medical history included gets pneumonia routinely during specific seasons. On an unknown date in October 2012, the patient was vaccinated with a dose of ZOSTAVAX (Lot number, expiry date were not reported) 0.65 milliliter (reported as standard dose), subcutaneously. Concomitant therapies included amoxicillin and PRILOSEC. The patient reported that after receiving ZOSTAVAX in October 2012, she developed a bad reaction on her arm where the injection site became red and itchy and then spread over a larger area in the arm. The patient also developed a pins and needles sensation around her neck and top of her back that occurred in January 2013 after the vaccination, on the same side of her body that the shot was given and eventually subsided approximately in January 2013 (reported as after 2 weeks). The patient explained that when she received the vaccine on an unknown date in October 2012, it felt slightly itchy and burned during administration and resolved on an unknown date in October 2012. After the painful administration on an unknown date in October 2012, the arm became swollen and developed a mark that lasted almost 4 months in decreasing severity and was recovering at the time of report. Diagnostic test was not performed. The patient sought medical attention (spoke to the doctor). No treatment was provided. The outcome of the events the injection site became red and itchy and then spread over a larger area in the arm was unknown. Additional information has been requested.
Pt states today that he had a reaction to RECOMBIVAX HB #2 in October 20008.
Bell's Palsy on the left side of my face.  Started with my upper lip on the left side, spread to the left side of my mouth the next day, and several hours later I am having trouble trying to close my left eye.
Dizziness; Double vision; Foggy head, not feeling herself; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), DIPLOPIA (Double vision) and FEELING ABNORMAL (Foggy head, not feeling herself) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 03-Mar-2021, the patient experienced DIZZINESS (Dizziness), DIPLOPIA (Double vision) and FEELING ABNORMAL (Foggy head, not feeling herself). At the time of the report, DIZZINESS (Dizziness), DIPLOPIA (Double vision) and FEELING ABNORMAL (Foggy head, not feeling herself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Fluttering heartbeat,shortness of breath,very ill with flu like symptoms for 2 days,bad headache for 2 days,loss of appetite and constantly dry throat.
Dizziness; Vertigo; Headaches; Tinnitus off and on for 9 weeks, and I'm still suffering; This is a spontaneous report from a non-contactable consumer (patient). A 34-years-old female patient received first dose of bnt162b2 (BNT162B2; Solution injection, Batch/Lot Number: EW0151), via an unspecified route of administration, administered in Arm Left on 11Apr2021 12:00 as single dose (at the age of 34-year-old) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took oxycodone. On 14Apr2021 07:00, 3 days after first vaccine shot, patient experienced dizziness, vertigo, cluster headache, tinnitus off and on for 9 weeks, and I m still suffering. The events were reported as disability or permanent damage. She received antibiotics treatment but didn't work. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive other medications within 2 weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient been not been tested for COVID-19. The patient underwent lab tests and procedures which included blood test which was normal. The outcome of the all the events were not recovered.  Follow-up attempts are not needed as the reporter is a non-contactable. No further information is expected.
8:00 am 3/3/2021 had severe muscle and joint aches. Area of injection was red all around in large area and warm to rich. Was lethargic.
Symptoms started the morning of December 9, I woke up with an itchy head, and started developing red itchy splotchy patches. They started on my neck and it spread to my upper back and spread down my body. I was in pain all weekend and finally went to urgent care, and started taking benadryl and Zyrtec. Any time I stop these medicines I get hives and dermotographia over most of my body. I stopped taking Escitolapram for months because I thought it was the cause but then nothing changed. Dr told me it's most likely my booster because she has other patients who have it too.
Symptoms: Covid Arm; and other adverse events. Timeline is as follows: Thurs. Mar 25 ? Day of injection: mild soreness at injection site.   Fri. Mar 26 ? slight headache, really sore arm (remains sore thru Mar 28); pale, bluish-red, nickel-sized mark at injection site; mild achy muscles/joints, legs felt heavy when walking. Afternoon and evening chills with low-grade fever 100.7   Sat. Mar 27? temperature 98.8. In afternoon, itchy COVID ARM rash appears as flat, red oval (about 1?x.75?) over left-arm injection site (Note: as reported previously to VAERS, Dose #1 Covid Arm rash was on my right arm, had basically disappeared by March 11. With the appearance of Dose #2 Covid Arm on my left arm, the right arm rash becomes faintly visible again for a couple days.)   Sun. Mar 28 ? temperature back to normal (97.7); rash enlarges to 2?x1.5?. Rash is not quite as red as first Covid Arm rash, but itches more than first.  Mon. Mar 29 ? in my right eye, experienced flashes of light and floaters Tues. Mar 30 ? rash very faint, still itches Wed. Mar 31 ? rash not visible, but area still itches Fri. Apr 2 ? rash is no longer visible.
Information has been received from a nurse practitioner concerning a 19 year old female patient with no previous medical history reported who on 27-MAR-2009 was vaccinated with the first dose of GARDASIL vaccine (Lot number 660616/0570X). There was no concomitant medication. On 27-MAR-2009, the patient experienced hives after receiving the first dose of GARDASIL vaccine. The patient's mother gave her BENADRYL and the hives resolved in 28-MAR-2009. The patient sought unspecified medical attention. Follow-up information has been received from a registered nurse concerning the 19 year old female patient with no known drug allergies, with a history of acute lymphocytic leukemia with a reaction to chemotherapy who on 27-MAR-2009 at 15:00 was vaccinated with the first dose of GARDASIL vaccine (Lot number 660616/0570X) in the left deltoid. Concomitant therapy included YAZ. On 27-MAR-2009, in Friday evening the patient broke in hives, the hives started on buttocks and arms, and began itching. The mother's patient stated that she put BENADRYL on the skin and administered oral BENADRYL, the patient went to the bed, sleep and woke up fine without hives. On 28-MAR-2009, the patient recovered from hives. No further information is available.
Patient received influenza and started getting an itchy throat. She walked into an urgent care center and received a Benadryl shot.  No relief so went to hospital to receive steroids.  On 5 days of steroid treatment.
Nausea; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) in the left arm on 31Mar2021 at 14:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included levothyroxine sodium (SYNTHROID) for unknown indication within two weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00 the patient experienced nausea and diarrhea. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events nausea and diarrhea were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Shots were given 2-09-09 (Monday).  Mom called Thursday 2-12-09, she reported following: Pt had slight fever and didn't feel great and some itching on 2-10-09 Tuesday.  Tuesday 2-10-09 PM swollen and red hands and both feet itched.  Wednesday 2-11-09 both hands swollen, bottom of 1 foot swollen and red could hardly walk.  Thursday 2-12-09 states foot and hands are better states has hives on L leg above knee lateral side.  Reports achy joints with rash.  I recommend they see a doctor.  States ok.  Tuesday 2-17-09 I spoke with mom.  She states that symptoms decreased gradually after Thursday and were all gone by Sunday 2-15-09.  She also stated that rash had developed below knees - at waist - buttocks and at level of bra strap Thursday but again were all gone by Sunday 2-15-09.  Also stated that the rash would come and go.  2/17/09 Mom states called a doctor's office on 2-12-09 said would not have appt till Tuesday 2-17-09 but that all they would do would be to give her BENADRYL told her if got worse go to ER.
THE PATIENT WAS SEATED IN THE LOBBY AFTER HIS IMMUNIZATION.  HE THEN  SAW A PATIENT FAINTED AND IMMEDIATELY PASSED OUT ALSO. PARAMEDICAS WERE CALLED AND AFTER EXAMINATION THEY TOOK HIM TO THE HOSPITAL
This case was reported by a other health professional and described the occurrence of vaccine underdose in a 19-year-old female patient who received HAVRIX 720 Junior (batch number M7L59, expiry date 26th December 2016). On an unknown date, the patient received HAVRIX 720 Junior. On an unknown date, an unknown time after receiving HAVRIX 720 Junior, the patient experienced vaccine underdose and wrong vaccine administered. On an unknown date, the outcome of the vaccine underdose and wrong vaccine administered were unknown.
Redness, induration right upper thigh. Noticed 3-23-04 (afebrile). Treatment: Ice pack.
No additional AE.; the vaccine was administered after a temperature excursion.; Information has been received from a nurse referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.     On 21-JAN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (0.5 milliliter, lot # U022321, expiration date:15-JUL-2023, strength, frequency and route were unknown) for prophylaxis (incorrect product storage). No additional adverse event was reported.          The stored temperature was -14.1 degree Celsius. The time frame was 12 minutes. There was no previous temperature excursion.
Arthritic pain both Shoulder Joints  /  Chronic Headaches / Numb Discomfort right rib cage / sudden rise in blood pressure
One bottle of Pfizer was dosed out 6 vaccines and then re-diluted and given 3 doses from the vial. This was caught and patient was called to come back and get another vaccine per manufacturer paperwork. Patient received another vaccine with no adverse reaction to date.
Presented for SOB, hypoxia, COVID s/s following known exposure. PCP tx with abx and steroid, no improvement.  Borderline diabetes, HTN, liver cirrhosis. Tx with IV steroid, remdesivir, abx, zinc, Vit C. Initially O2 w/NC, progressed to Airvo. Pt requested to go home while still on Airvo. Pt removed pulse Ox and Airvo and signed out AMA.
Patient became febrile 5 days after vaccination with second COVID Pfizer Vaccine. She was admitted to hospital with fever and myositis w/ b/l thigh pain w/ difficulty walking on 9/29/21. CK elevated on admission and down trending. She had complete resolution of symptoms on 10/1/21.
This spontaneous report has been received from an office manager refers to an unspecified number of patients of unknown age and gender. Concurrent conditions and pertinent medical history were not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of MMR II (lot # J016232, exp. date 19-DEC-2015), (strength, route of administration and dose were not provided). There was no concomitant medication reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
The day after receiving the booster, I began to palpitate off and on.  Palpitations became more frequent as the days passed.  I became light-headed as well.  While wearing a 2-week monitor, I passed out at home and split my lip.  I went to the emergency room.  One week later, I was scheduled to have an ablation.  I had developed A fib.  Presently, the procedure is a success.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with VARIVAX lot # L012036 for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date the patient experienced incorrect product storage. No adverse event was reported. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to VARIVAX. {Additional information has been requested. / Additional information is not expected.} Sender's Comments: US-009507513-1708USA005191.
Mother reports child with facial swelling and vomiting started 2/6/09. Seen ER at medical center 2/6/09. Mom reports "Dr said she had allergic reaction to immunizations. Given "med" for vomiting and told to give her BENADRYL. Still vomiting 2/9 has /// /// 2/9/09
Donor stated developed "Rash with itching" 3 to 4 days post immunization administration. Donor stated that he applied Calamine lotion to "rash". Denies any trouble with breathing or any other symptoms.
THE FIRST EIGHT DAYS AFTER VACCINATION, APRIL 30 TO MAY 8, INTENSE PAIN AND SWELLING IN THE PART OF THE LEFT ARM BETWEEN THE ELBOW AND SHOULDER, IN THE SAME AREA OF THE ARM FROM MAY 9 TO 16, MODERATE PAIN . ON MAY 17 AT 11.30 AM, SWEATING FROM FEET TO HEAD FOR 5 SECONDS, IMMEDIATELY FEELING COLD TO A DEGREE OF FREEZING FROM HEAD TO FEET FOR 7 SECONDS, IN THE MIDDLE OF THAT TIME, 3 SECONDS, I FELT I LOST MY STRENGTH IN MIS LEGS, AND I WALKED A DISTANCE OF 20 METERS WITH THE PURPOSE OF BEING IN A CLEAR AREA WHERE MY CO-WORKERS COULD SEE ME AND GIVE ME HELP. WHEN I WAS CLOSE TO THE GROUND, A COMPANION STOPPED ME WITH HIS ARMS, THEY CALLED THE AMBULANCE, I WAS TRANSFERRED TO FACILITY.
Information has been received from a healthcare worker concerning a patient of unknown age and gender, who on 18-SEP-2012 and on 16-OCT-2012 was vaccinated with the first and second dose of PNEUMOVAX 23, intramuscularly (doses, and lot #s not reported). No adverse effects reported. Additional information has been requested.
This spontaneous report as received from a consumer refers to a 61 year old male patient. Patient had Bell's palsy 20 years ago. Patient had no drug reactions and allergies. On 22-JUL-2014 the patient was vaccinated with ZOSTAVAX (lot#, dose, route not reported) at his employers Health Fair in left arm for Prevention for "Shingles". No concomitant medications were reported. The patient stated that approximately 72 hours later (On 25-JUL-2014) he developed an itchy, burning patch on the left side of his rib cage that progressed to his back over a few days. The patient visited his physician who determined it was a case of "Shingles". The physician prescribed an anti-viral medication (brand, manufacturer, & dose unspecified). There was no product quality complaint. The patient sought medical attention by office visit. No lab diagnostics studies were performed. The outcome of shingles was reported as recovering/resolving. The causality is unknown. Additional information has been requested.
Patient was observed by staff after receiving Janssen COVID19 Vaccination. During observation patient reported: Other: pt reported throat tightness approx. 10" after Janssen Covid-19 vaccine injection, anxious it may be an allergic reaction; pt. moved to stretcher, head down, feet up, oxygen 4L via NC applied, 9:15am Epinephrine 0.3mL administered IM to left glut., BP 130/104, pulse 76, pulse ox 99; 9:20 am ambulance called, BP 128/94-74, pulse ox 99; ambulance arrived at 9:30am, 9:34 am pt. transferred to ambulance stretcher with head at ~90 degrees, patient was continuously monitored by FNP, RN. and CNA -- until patient transferred to ambulance at 9:35am for transport to hospital. Pt. has hx of similar symptoms to PCN.